Paradoxical stimulation of matrix metalloproteinase-9 expression in HT1080 cells by a broad-spectrum hydroxamate-based matrix metalloproteinase inhibitor

被引:3
作者
Maquoi, E
Munaut, G
Colige, A
Lambert, C
Frankenne, F
Noël, A
Grams, F
Krell, HW
Foidart, JM
机构
[1] Univ Liege, Lab Biol Tumeurs & Dev, B-4000 Liege, Belgium
[2] Univ Liege, Lab Biol Tussus Conjonctifs, B-4000 Liege, Belgium
[3] Boehringer Mannheim GmbH, Penzberg, Germany
[4] Boehringer Mannheim GmbH, D-6800 Mannheim, Germany
来源
INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS | 1999年 / 878卷
关键词
D O I
10.1111/j.1749-6632.1999.tb07779.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:744 / 746
页数:3
相关论文
共 3 条
[1]  
CAMPION C, 1990, Patent No. 5719
[2]   Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor [J].
Maquoi, E ;
Noël, A ;
Frankenne, F ;
Angliker, H ;
Murphy, G ;
Foidart, JM .
FEBS LETTERS, 1998, 424 (03) :262-266
[3]  
Talbot DC, 1996, EUR J CANCER, V32A, P2528